Cargando…

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

Detalles Bibliográficos
Autores principales:	Sun, Hao, Li, Yingmei, Zhang, Peng, Xing, Haizhou, Zhao, Song, Song, Yongping, Wan, Dingming, Yu, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773589/ https://www.ncbi.nlm.nih.gov/pubmed/36544222 http://dx.doi.org/10.1186/s40364-022-00445-6

Ejemplares similares

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
por: Sun, Hao, et al.
Publicado: (2022)

Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
por: Cao, Weijie, et al.
Publicado: (2022)

Deficient Regulatory Innate Lymphoid Cells and Differential Expression of miRNAs in Acute Myeloid Leukemia Quantified by Next Generation Sequence
por: Yu, Jifeng, et al.
Publicado: (2019)

Correction: Identification of Potential Pathway Mediation Targets in Toll-like Receptor Signaling
por: Li, Fan, et al.
Publicado: (2009)

Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Correction Vol. 8, No. 7
Publicado: (2002)

Correction, Vol. 8, No. 7
Publicado: (2002)

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
Publicado: (2022)

Correction: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
Publicado: (2020)

Clinical Characteristics And Outcome Of Biphenotypic Acute Leukemia: 10 Case Reports And Literature Review
por: Yu, Jifeng, et al.
Publicado: (2019)

Clinical implications of recurrent gene mutations in acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2021)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Correction: Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo
Publicado: (2015)

Correction: mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo
por: Zeyer, Franziska, et al.
Publicado: (2018)

Correction: The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast
por: Yu, Wenwen, et al.
Publicado: (2023)

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
por: Deng, Shuanglin, et al.
Publicado: (2014)

Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
por: Rostamizadeh, Leila, et al.
Publicado: (2022)

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
por: Hotz, Christian, et al.
Publicado: (2012)

Correction: Retinal Muller Glia Initiate Innate Response to Infectious Stimuli via Toll-Like Receptor Signaling
por: Kumar, Ashok, et al.
Publicado: (2012)

Correction: Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
por: Ma, Yonggang, et al.
Publicado: (2012)

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
por: Matissek, Stephan J., et al.
Publicado: (2023)

Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
por: Chatterjee, Piyali, et al.
Publicado: (2012)

Correction: Polygonum cuspidatum and Its Active Components Inhibit Replication of the Influenza Virus through Toll-Like Receptor 9-Induced Interferon Beta Expression
por: Lin, Chao-jen, et al.
Publicado: (2015)

Correction: Serrano, R.; Wesch, D.; Kabelitz, D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Cells 2020, 9, 713
por: Serrano, Ruben, et al.
Publicado: (2020)

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation
por: Yu, Jifeng, et al.
Publicado: (2020)

Correction: The Role of Calpain-Myosin 9-Rab7b Pathway in Mediating the Expression of Toll-Like Receptor 4 in Platelets: A Novel Mechanism Involved in α-Granules Trafficking
Publicado: (2014)

Correction: Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence
Publicado: (2014)

Correction: Toll-Like Receptor Signaling in Vertebrates: Testing the Integration of Protein, Complex, and Pathway Data in the Protein Ontology Framework
por: Arighi, Cecilia, et al.
Publicado: (2015)

Correction: Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-Like Receptor Pathway Deregulation in Colorectal Cancer
por: Xu, Ye, et al.
Publicado: (2013)

Correction to: Fetal Membrane Inflammation Induces Preterm Birth Via Toll-Like Receptor 2 in Mice With Chronic Gingivitis
por: Konishi, Haruhisa, et al.
Publicado: (2021)

Correction: Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent
por: Dickinson-Copeland, Carmen M., et al.
Publicado: (2016)

Correction to: Aerobic but not Resistance Exercise Can Induce Inflammatory Pathways via Toll-Like 2 and 4: a Systematic Review
por: Cavalcante, P. A. M., et al.
Publicado: (2018)

Correction: Pathophysiology of Endometriosis: Role of High Mobility Group Box-1 and Toll-Like Receptor 4 Developing Inflammation in Endometrium
por: Yun, Bo Hyon, et al.
Publicado: (2018)

Correction: Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage
por: Sokół, Bartosz, et al.
Publicado: (2016)

Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021)

Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Publicado: (2020)

Correction to: Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways
por: Zheng, Wenjin, et al.
Publicado: (2020)

Correction: Toll-like receptor 9 deficiency induces osteoclastic bone loss via gut microbiota-associated systemic chronic inflammation
por: Ding, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_27evkosun7o1tr25ajd9vsrqef